ProRx recalls Semaglutide 6mg/2.4mL injections due to lack of sterility assurance. Affected lots from June 2024 production; stop using immediately if you have this medication.
Lack of Assurance of Sterility
ProRx is recalling Semaglutide injections that may not be sterile, which could lead to infections. This recall affects patients using the medication for weight management or diabetes treatment.
The injections may not be sterile, which can cause infections when injected into the body. This is a serious risk because the medication is used directly into the bloodstream.
People with prescriptions for Semaglutide injections from ProRx. Those using the medication for weight loss or diabetes are most at risk.
Check the product label for the lot numbers: Prorx051425-2, Prorx051425-3, or Prorx051425-4. The product was manufactured in June 2024 at ProRx's facility in Exton, PA.
Discard the vial if you have the recalled lot numbers.
No, the product may not be sterile and could cause infections. Do not use the recalled vials.
Lot numbers Prorx051425-2, Prorx051425-3, and Prorx051425-4.
The product was manufactured at ProRx's facility in Exton, PA.
We’ve drafted a message you can send ProRx to request your refund or repair — edit it as you like.
Subject: Recall D-0116-2026 — ProRx ProRx Hello, I own a ProRx that is covered by recall D-0116-2026 from ProRx. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
